Annual report
8095.TEDINET S100QADE
Period2021-12-01 → 2022-11-30
Filed2023-02-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100SOBI (2024-01-25).
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales |
| Revenue | ¥65.3bn | 2019-12-01 → 2020-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.6bn | 2018-12-01 → 2019-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.1bn | 2017-12-01 → 2018-11-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥820m | 2021-12-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2020-12-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2019-12-01 → 2020-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2018-12-01 → 2019-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2017-12-01 → 2018-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.4bn | 2021-12-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.1bn | 2020-12-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2019-12-01 → 2020-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2018-12-01 → 2019-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2017-12-01 → 2018-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥574m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥54.3bn | at 2020-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥44.7bn | at 2019-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥41.4bn | at 2018-11-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥21.7bn | at 2020-11-30d | Cons. | Net assets |
| Net assets / equity | ¥20.4bn | at 2019-11-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥19.2bn | at 2018-11-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.9bn | at 2021-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.8bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-11-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2019-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.5bn | at 2018-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.1bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2017-12-01 → 2018-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.3bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2017-12-01 → 2018-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.8bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥324m | 2018-12-01 → 2019-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥138m | 2017-12-01 → 2018-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.33 | 2019-12-01 → 2020-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.01 | 2018-12-01 → 2019-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.75 | 2017-12-01 → 2018-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥685.24 | at 2022-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥677.09 | at 2021-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥656.54 | at 2020-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥624.09 | at 2019-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥591.72 | at 2018-11-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2020-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.7% | at 2019-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2018-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 2.1% | 2021-12-01 → 2022-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-12-01 → 2021-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2019-12-01 → 2020-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2018-12-01 → 2019-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2017-12-01 → 2018-11-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,383 | at 2022-11-30 | Cons. | Number of employees |
| Employees | 1,368 | at 2021-11-30 | Cons. | Number of employees |
| Employees | 1,295 | at 2020-11-30d | Cons. | Number of employees |
| Employees | 957 | at 2019-11-30d | Cons. | Number of employees |
| Employees | 954 | at 2018-11-30d | Cons. | Number of employees |
| Revenue | ¥2.8bn | 2021-12-01 → 2022-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥23.0bn | 2020-12-01 → 2021-11-30 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2020-12-01 → 2021-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥47.2bn | 2019-12-01 → 2020-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥49.2bn | 2018-12-01 → 2019-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥48.4bn | 2017-12-01 → 2018-11-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥282m | 2021-12-01 → 2022-11-30 | Standalone | Operating income |
| Operating income | −¥186m | 2020-12-01 → 2021-11-30 | Standalone | Operating income |
| Ordinary income | ¥290m | 2021-12-01 → 2022-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥304m | 2020-12-01 → 2021-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥290m | 2019-12-01 → 2020-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥544m | 2018-12-01 → 2019-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥746m | 2017-12-01 → 2018-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2021-12-01 → 2022-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2020-12-01 → 2021-11-30 | Standalone | Income before income taxes |
| Net income | ¥831m | 2021-12-01 → 2022-11-30 | Standalone | Profit loss |
| Net income | ¥788m | 2020-12-01 → 2021-11-30 | Standalone | Profit loss |
| Net income | ¥255m | 2019-12-01 → 2020-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥491m | 2018-12-01 → 2019-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥540m | 2017-12-01 → 2018-11-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥30.1bn | at 2022-11-30 | Standalone | Assets |
| Total assets | ¥30.2bn | at 2021-11-30 | Standalone | Assets |
| Total assets | ¥39.3bn | at 2020-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥33.9bn | at 2019-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥31.8bn | at 2018-11-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥16.2bn | at 2022-11-30 | Standalone | Liabilities |
| Total liabilities | ¥16.2bn | at 2021-11-30 | Standalone | Liabilities |
| Net assets / equity | ¥13.9bn | at 2022-11-30 | Standalone | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-11-30 | Standalone | Net assets |
| Net assets / equity | ¥12.9bn | at 2020-11-30d | Standalone | Net assets |
| Net assets / equity | ¥13.4bn | at 2019-11-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥13.2bn | at 2018-11-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2022-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2021-11-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥20.88 | 2021-12-01 → 2022-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.27 | 2020-12-01 → 2021-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.75 | 2019-12-01 → 2020-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.05 | 2018-12-01 → 2019-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.7 | 2017-12-01 → 2018-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.16 | 2020-12-01 → 2021-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥18 | 2021-12-01 → 2022-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2020-12-01 → 2021-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2019-12-01 → 2020-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥13 | 2018-12-01 → 2019-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10.5 | 2017-12-01 → 2018-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥352.82 | at 2022-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.47 | at 2021-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥392.26 | at 2020-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥408.5 | at 2019-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥407.59 | at 2018-11-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.2% | at 2022-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2021-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.9% | at 2020-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2019-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.5% | at 2018-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.0% | 2021-12-01 → 2022-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-12-01 → 2021-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.9% | 2019-12-01 → 2020-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2018-12-01 → 2019-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2017-12-01 → 2018-11-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 40,772,366 | at 2022-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,087 | at 2021-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,729,839 | at 2020-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,636,058 | at 2019-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,508,789 | at 2018-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 105 | at 2022-11-30 | Standalone | Number of employees |
| Employees | 109 | at 2021-11-30 | Standalone | Number of employees |
| Employees | 323 | at 2020-11-30d | Standalone | Number of employees |
| Employees | 308 | at 2019-11-30d | Standalone | Number of employees |
| Employees | 293 | at 2018-11-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 79
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-12-01 → 2022-11-30 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-11-30 | 5 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-11-30 | −¥42m |
| Reconciling Itemsreconciling | depreciation | 2021-12-01 → 2022-11-30 | ¥428m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-11-30 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-11-30 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-11-30 | ¥236m |
| Fine Chemicalsreportable segment | depreciation | 2021-12-01 → 2022-11-30 | ¥898m |
| Fine Chemicalsreportable segment | employees | at 2022-11-30 | 428 pure |
| Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥15.2bn |
| Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥14.6bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥587m |
| Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-11-30 | ¥248m |
| Health And Beauty Care Foodreportable segment | depreciation | 2021-12-01 → 2022-11-30 | ¥127m |
| Health And Beauty Care Foodreportable segment | employees | at 2022-11-30 | 202 pure |
| Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥14.1bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥14.0bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥117m |
| Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-11-30 | ¥142m |
| Industrial Chemicalsreportable segment | depreciation | 2021-12-01 → 2022-11-30 | ¥335m |
| Industrial Chemicalsreportable segment | employees | at 2022-11-30 | 367 pure |
| Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥9.4bn |
| Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥9.3bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥99m |
| Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-11-30 | −¥157m |
| Medicalreportable segment | depreciation | 2021-12-01 → 2022-11-30 | ¥329m |
| Medicalreportable segment | employees | at 2022-11-30 | 268 pure |
| Medicalreportable segment | revenue | 2021-12-01 → 2022-11-30 | ¥12.2bn |
| Medicalreportable segment | revenue external | 2021-12-01 → 2022-11-30 | ¥11.8bn |
| Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥446m |
| Medicalreportable segment | segment profit | 2021-12-01 → 2022-11-30 | ¥393m |
| —segment total | depreciation | 2021-12-01 → 2022-11-30 | ¥1.7bn |
| —segment total | employees | at 2022-11-30 | 1265 pure |
| —segment total | revenue | 2021-12-01 → 2022-11-30 | ¥50.9bn |
| —segment total | revenue external | 2021-12-01 → 2022-11-30 | ¥49.6bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥1.2bn |
| —segment total | segment profit | 2021-12-01 → 2022-11-30 | ¥626m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-12-01 → 2022-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-11-30 | ¥50.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-11-30 | ¥49.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-11-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-11-30 | ¥584m |
| Reconciling Itemsreconciling | depreciation | 2020-12-01 → 2021-11-30 | ¥177m |
| Reconciling Itemsreconciling | revenue | 2020-12-01 → 2021-11-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue external | 2020-12-01 → 2021-11-30 | ¥72,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-12-01 → 2021-11-30 | −¥1.6bn |
| Reconciling Itemsreconciling | segment profit | 2020-12-01 → 2021-11-30 | −¥102m |
| Fine Chemicalsreportable segment | depreciation | 2020-12-01 → 2021-11-30 | ¥863m |
| Fine Chemicalsreportable segment | revenue | 2020-12-01 → 2021-11-30 | ¥23.9bn |
| Fine Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-11-30 | ¥22.9bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥1.0bn |
| Fine Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-11-30 | ¥1.4bn |
| Health And Beauty Care Foodreportable segment | depreciation | 2020-12-01 → 2021-11-30 | ¥105m |
| Health And Beauty Care Foodreportable segment | revenue | 2020-12-01 → 2021-11-30 | ¥28.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2020-12-01 → 2021-11-30 | ¥28.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥64m |
| Health And Beauty Care Foodreportable segment | segment profit | 2020-12-01 → 2021-11-30 | −¥343m |
| Industrial Chemicalsreportable segment | depreciation | 2020-12-01 → 2021-11-30 | ¥288m |
| Industrial Chemicalsreportable segment | revenue | 2020-12-01 → 2021-11-30 | ¥8.8bn |
| Industrial Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-11-30 | ¥8.7bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥69m |
| Industrial Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-11-30 | ¥384m |
| Medicalreportable segment | depreciation | 2020-12-01 → 2021-11-30 | ¥397m |
| Medicalreportable segment | revenue | 2020-12-01 → 2021-11-30 | ¥12.9bn |
| Medicalreportable segment | revenue external | 2020-12-01 → 2021-11-30 | ¥12.5bn |
| Medicalreportable segment | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥416m |
| Medicalreportable segment | segment profit | 2020-12-01 → 2021-11-30 | ¥908m |
| —segment total | depreciation | 2020-12-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue | 2020-12-01 → 2021-11-30 | ¥73.9bn |
| —segment total | revenue external | 2020-12-01 → 2021-11-30 | ¥72.3bn |
| —segment total | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥1.6bn |
| —segment total | segment profit | 2020-12-01 → 2021-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-12-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-11-30 | ¥73.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-11-30 | ¥72.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-12-01 → 2021-11-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-11-30 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,999
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in retained earnings of subsidiaries due to change in scope of consolidation | CurrentYearDuration | 258000 | JPY |
| Change in treasury shares of parent arising from transactions with non controlling shareholders | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | － | JPY |
| Change in treasury shares of parent arising from transactions with non controlling shareholders | CurrentYearDuration | -6874000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 21134000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_DeferredGainsOrLossesOnHedgesMember | -3262000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember | 87227000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember | 103588000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | 208688000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_NonControllingInterestsMember | 75507000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration | 284196000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 21134000 | JPY |
| Total changes of items during the period | CurrentYearDuration_DeferredGainsOrLossesOnHedgesMember | -3262000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember | 87227000 | JPY |
| Total changes of items during the period | CurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember | 103588000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | 208688000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonControllingInterestsMember | 75507000 | JPY |
| Total changes of items during the period | CurrentYearDuration | -94666000 | JPY |
| Net assets | CurrentYearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 1007002000 | JPY |
| Net assets | CurrentYearInstant_DeferredGainsOrLossesOnHedgesMember | -4026000 | JPY |
| Net assets | CurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember | 191067000 | JPY |
| Net assets | CurrentYearInstant_RemeasurementsOfDefinedBenefitPlansMember | 196203000 | JPY |
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | 1390246000 | JPY |
| Net assets | CurrentYearInstant_NonControllingInterestsMember | 82094000 | JPY |
| Net assets | CurrentYearInstant | 27068701000 | JPY |
| Income before income taxes | Prior1YearDuration | 3079272000 | JPY |
| Income before income taxes | CurrentYearDuration | 1418325000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 1830238000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 2117715000 | JPY |
| Share based compensation expenses ope cf | Prior1YearDuration | 43796000 | JPY |
| Share based compensation expenses ope cf | CurrentYearDuration | 50543000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -6527000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | -3112000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | -39708000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | 117502000 | JPY |
| Increase decrease in provision for product warranties ope cf | Prior1YearDuration | 1795000 | JPY |
| Increase decrease in provision for product warranties ope cf | CurrentYearDuration | 3547000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | -7322000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | -58540000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -67622000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -63299000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 59811000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 52556000 | JPY |
| Guarantee commission ope cf | Prior1YearDuration | － | JPY |
| Guarantee commission ope cf | CurrentYearDuration | 28579000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | 5142000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | 58223000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | － | JPY |
| Impairment loss ope cf | CurrentYearDuration | 36201000 | JPY |
| Loss on withdrawal from business ope cf | Prior1YearDuration | － | JPY |
| Loss on withdrawal from business ope cf | CurrentYearDuration | 25000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |